Seaport Therapeutics, Inc. Common Stock· SPTX
🇺🇸 US · SmallBroad USNASDAQ
- Price
- $20.65
- Day
- +0.93%
- Mkt Cap
- $1.11B
- 52W Range
- $14.85 – $23.00
- Volume
- 119.6K
- Beta
- 0.00
Find a company by name or ticker and open its page
Snapshot of fundamentals, performance, and 5D scores.
Business fundamentals and company information
Recent price action and historical returns
How the business makes money, by product and geography
Five lenses on the stock. Click any card to dive deeper.
How to read these dimensions
The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.
Recent news headlines and analyst price-target moves
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
BOSTON--(BUSINESS WIRE)--Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress.
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
[url="]Seaport Therapeutics, Inc.[/url], (Nasdaq: SPTX) (âSeaportâ or the âCompanyâ), a clinical-stage therapeutics company that is inventing and develo